The tumor-infiltrating CD4+ cells in the combination group also showed higher expression of the costimulatory marker GITR and a greater proportion of PD-1+GrzB+ cells (p<0.0001 and p=0.0007, respectively, figure 6K). This evidence concerns the gene TNFRSF18 and neoplasm.